News GSK wins the vote contest in FDA’s RSV vaccine panels Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.
News Ex-NHS chief negotiator joins Newmarket Strategy Pharma veteran Blake Dark joins the healthcare and life sciences consultancy as senior partner.
News FDA rejects Cytokinetics’ heart failure drug Firm will request a meeting with FDA, but may have to switch focus to folow-up drug aficamten.
News Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn There was debate about cases of Guillain Barré and the population of the phase 3 RENOIR trial.
News Santhera shores up funding ahead of vamorolone verdict The FDA is due to deliver a verdict on vamorolone in Duchenne muscular dystrophy in October.
News Northern Ireland Brexit deal restores MHRA jurisdiction Regulator regains the power to approve medicines in Northern Ireland under Windsor Framework.
News Third Rock in $2bn drug-hunting pact with China's Funnel New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.